Information for Ipamorelin
Ipamorelin is a synthetic pentapeptide that selectively activates ghrelin receptors to stimulate growth hormone release with minimal impact on other endocrine pathways (Adeghate & Ponery 2004; Greenwood-Van Meerveld et al. 2012). In vivo studies in rodents have shown that ipamorelin enhances bone mineral content through increased bone size and supports gastrointestinal motility via cholinergic mechanisms (Svensson et al. 2000; Greenwood-Van Meerveld et al. 2012).
Research Certificates of Analysis
7.09mg
Task #42400
Batch #05072024
05/16/2024
GMP Certificates of Analysis
5mg
Laboratory ID V250321-20 004
Lot # 11325
04/02/2025
5.2mg
Batch #PKIPA1011525
01/15/2025
5.7mg
Batch #PKIPAM5924
09/10/2024
Ipamorelin Peptide Structure
2D structure image of CID 9831659 (Ipamorelin):
PubChem Identifier: CID 9831659
URL: https://pubchem.ncbi.nlm.nih.gov/compound/9831659
Peptide Sequence: Aib-His-D-2Nal-D-Phe-Lys
Molecular Formula: C38H49N9O5
Molecular Weight: 711.868 g/mol
CAS Number: 170851-70-4
Product Usage
This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.
